Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin vs Pregabalin for Early Neuropathic Pain After Breast Cancer Surgery
NCT03794388Phase 3Completed
- Sponsor
- Institut Cancérologique de l'Ouest
- Start
- Mar 2019
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of capsaicin in neuropathic pain (2 arms), sponsored by Institut Cancérologique de l'Ouest. Primary endpoint: Neuropathic Pain Score at 2 months. Started Mar 2019; status: completed.
02
Drugs
capsaicin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT03794388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03794388.